Dr. Townley is a senior research scientist and lecturer at Oxford University, based at the University‘s Begbroke Science Park. Her research group focuses on the use of nanoparticles for therapy, imaging and targeted drug delivery in a number of different cancer types, but with particular emphasis on paediatric cancers. She is also a co-founder and director of the recently founded Xerion Healthcare Ltd. – a University spin-out company set to commercialize rare earth doped titania nanoparticles for augmented radiotherapy.